JYNT

The Joint Corp.

Price

$8.75

return (12m)

-23.56%

p/e

38.39

p/bv

8.03

DIVIDEND YIELD

0.00%

JYNT price

Joint

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment JYNT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.29%

3 months

2.01%

1 year

-23.56%

2 years

-37.48%

5 years

-89.71%

10 years

0.00%

Fundamentals JYNT

Valuation

P/E

38.39

Sector -2.36

Industry 0.98

P/BV

8.03

Sector 2.16

Industry 2.53

P/Revenue (PSR)

2.20

Sector 2.00

Industry 0.76

P/EBITDA

51.83

Sector -0.13

Industry 1.08

P/EBIT

185.66

Sector -2.10

Industry 3.17

P/Total Assets

2.15

Sector 1.17

Industry 0.93

EPS

0.23

Sector -0.93

Industry -0.57

BVPS

1.11

Sector 3.88

Industry 5.17

Efficiency

Gross Margin

80.63%

Sector 44.07%

Industry 30.88%

Operating Margin

1.18%

Sector -25.88%

Industry -7.64%

Net Profit Margins

5.72%

Sector -30.34%

Industry -16.97%

Profitability

ROE

20.92%

Sector -34.57%

Industry -29.67%

ROA

5.59%

Sector -28.64%

Industry -15.42%

ROIC

10.41%

Sector -441.27%

Industry -111.79%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Debt

Equity/Assets

0.27

Sector 0.43

Industry 0.26

Liabilities/Assets

0.73

Sector 0.46

Industry 0.48

Growth

5Y Revenue CAGR

-6.68%

Sector -

Industry -

5Y Earnings CAGR

-15.59%

Sector -

Industry -

FAIR VALUE OF Joint ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$8.75

Fair Value

$2.40

Upside Return potential.

-72.62%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals JYNT

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JYNT	38.39	8.03	20.92%	0.00%	$124.39 M	5.72%
CI	11.58	1.78	15.39%	2.16%	$75.20 B	2.34%
UHS	6.06	1.21	20.00%	0.53%	$9.22 B	8.56%
DGX	22.66	3.00	13.22%	1.55%	$23.20 B	9.08%
STRRP	8.16	2.56	31.31%	9.43%	$163.57 M	25.96%
ENSG	27.54	4.22	15.33%	0.15%	$10.01 B	6.89%
CRVL	28.24	7.90	27.99%	0.00%	$3.12 B	11.51%
OPCH	16.48	2.51	15.26%	0.00%	$3.40 B	3.64%
MGLN	8.00	1.53	19.13%	0.00%	$2.42 B	6.38%
PGNY	37.63	5.80	15.40%	0.00%	$2.55 B	5.23%
VAR	58.58	7.26	12.40%	0.00%	$16.26 B	5.85%
PNTG	48.21	3.75	7.79%	0.00%	$1.46 B	2.96%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

JYNT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Joint

The Joint Corp.

Average Investor10 user rating

4.0 (1 people)

United States

16 years

Founded: 2010

2014

Time since IPO - 12 years

425

Employees

The Joint Corp. (United States) is listed on the Nasdaq and has a market capitalization of $124.39 million, with shareholders equity totaling $15.49 million.

The company employs approximately 425 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, The Joint Corp. reported $56.64 million in revenue, generating net income of $3.24 million.

Key financial metrics include a P/E ratio of 38.39, a price-to-book (P/B) ratio of 8.03, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker JYNT.

Market cap

$124.39 million

Net worth

$15.49 million

$15,490,000.00

Assets

$57.92 million

$57,920,000.00

Total Shares Outstanding

14.00 million

14,000,000

Average Daily Trading Volume

$125.34 Thousand

$125,338.00

Sector

Health

Industry

Health Establishments

JYNT

JYNT revenue and profits

Financial Results JYNT

DRAG THE FRAME TO SEE MORE DATA

JYNT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$109.45 85,17% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$287.16 --0,45% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$67.22 145,04% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$407.13 85,54% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$43.80 --5,01% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$1,163.75 51,17% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$371.79 2,66% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$154.86 38,31% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56